It has been reported to stabilize several oncogenic proteins, and inhibiting HSP90 has been shown to result in the misfolding and degradation of oncoproteins, thereby suppressing malignant transformation in various cancers, including HCC and gastric cancer [37, 38]. The gene discussed is HSP90AA1; the disease is hepatocellular carcinoma.